KEI’s morning intervention: KEI thanks the WHO for approving a 1pm side event, in room W1, where several NGOs will provide reflections on this negotiation. On a different note, among the recent events that have shocked the world are attacks… Continue Reading
Some notes on the informal negotiations on the footnote in Article 11 on the nature of the provisions for transfer of technology in the agreement. Mutually Agreed Process (MAP) With regard to the informal negotiations over the footnote to Article… Continue Reading
These are notes from KEI’s February 18 morning intervention: Regarding the footnote to Article 11, on technology transfer, there has been a long standing dispute over the use of words or phrases like voluntary, mutually agreed terms, in the context… Continue Reading
Some notes on day 1 of the WHO INB 13 negotiations a pandemic agreement. The Feb 6, 2025 version of the negotiating text is here: 6Feb2025-INB-text This is note from KEI’s morning intervention on the footnote in Article 11 on… Continue Reading
Introduction In January 2025, the National Institutes of Health (NIH) introduced a new NIH Intramural Research Program Access Planning Policy (“IRP Access Planning Policy” or “Policy”). An NIH web page provides links to several documents describing the policy: https://osp.od.nih.gov/policies/innovation-and-translation#tab1/ The… Continue Reading
KEI-NIH-T-Cure-Biosciences22Oct2024 Knowledge Ecology International (KEI) objects to the “Prospective Grant of an Exclusive Patent License: Anti-KK-LC-1 T Cell Receptors” (89 FR 81089) to T-Cure Biosciences, Inc. (T-Cure). Among other things, KEI said the NIH needs to be more forthcoming in… Continue Reading
KEI2HHS19Sep2024 September 19, 2024 Emily Bleimund, JD, MA Director, Office of Trade and Health U.S. Department of Health and Human Services Steven T. Smith National Institute of Allergy and Infectious Diseases (NIAID) Representative, Geneva, Switzerland Dear Emily and Steven, I… Continue Reading